Idorsia
Joerg Velker is a seasoned legal professional with extensive experience in the pharmaceutical industry, currently serving as Chief Patent Counsel at Idorsia Pharmaceuticals Ltd since June 2017. Prior to this role, Joerg held various positions at Actelion, including Senior Patent Counsel, Patent Counsel/EU Patent Attorney, Patent Trainee, and Lab Head of Medicinal Chemistry from July 2001 to June 2017. Academically, Joerg has a rich background in the sciences with a Diplom from RWTH Aachen University, postdoctoral studies at Scripps Research and Faculté de Pharma in Strasbourg, and a Thèse from Université de Neuchatel focusing on tandem reactions.
This person is not in any teams
This person is not in any offices
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.